Stefania Morganti
- Oncology top 2%
- Cancer Research top 5%
- Pulmonary and Respiratory Medicine top 5%
- Radiology, Nuclear Medicine and Imaging top 5%
- Molecular Biology
- Co-authors
- Giuseppe CuriglianoPaolo TarantinoCarmen CriscitielloEmanuela FerraroAntonio MarraGiulia VialeDario TrapaniSara M. Tolaney
- Topics
- HER2/EGFR in Cancer Research (21 papers)Cancer Genomics and Diagnostics (14 papers)Advanced Breast Cancer Therapies (13 papers)
- Journals
- Journal of Clinical OncologySHILAP Revista de lepidopterologíaJNCI Journal of the National Cancer Institute
- Partner nations
- ItalyUnited StatesFrance
In The Last Decade
Stefania Morganti
52 papers receiving 1.5k citations
Hit Papers
Peers
Comparison fields: 5 of 98
- Oncology 1.1k
- Cancer Research 426
- Pulmonary and Respiratory Medicine 403
- Radiology, Nuclear Medicine and Imaging 399
- Molecular Biology 349
Countries citing papers authored by Stefania Morganti
This map shows the geographic impact of Stefania Morganti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stefania Morganti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stefania Morganti more than expected).
Fields of papers citing papers by Stefania Morganti
This network shows the impact of papers produced by Stefania Morganti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stefania Morganti. The network helps show where Stefania Morganti may publish in the future.
Co-authorship network of co-authors of Stefania Morganti
This figure shows the co-authorship network connecting the top 25 collaborators of Stefania Morganti. A scholar is included among the top collaborators of Stefania Morganti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stefania Morganti. Stefania Morganti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 4 | |
| 3 | 16 | |
| 4 | 12 | |
| 5 | 16 | |
| 6 | 1 | |
| 7 | 15 | |
| 8 | 9 | |
| 9 | 24 | |
| 10 | 8 | |
| 11 | 57 | |
| 12 | 10 | |
| 13 | 26 | |
| 14 | Antibody–drug conjugates in solid tumors: a look into novel targetsbreakdown → | 180 |
| 15 | HER2-Low Breast Cancer: Pathological and Clinical Landscapebreakdown → | 490 |
| 16 | 5 | |
| 17 | 32 | |
| 18 | 1 | |
| 19 | 2 | |
| 20 | 88 |
About Stefania Morganti
Stefania Morganti is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine, having authored 56 papers that have together received 1.5k indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (21 papers), Cancer Genomics and Diagnostics (14 papers) and Advanced Breast Cancer Therapies (13 papers). The work is most often cited by research in Oncology (1.1k citations), Cancer Research (426 citations) and Radiology, Nuclear Medicine and Imaging (399 citations). Stefania Morganti has collaborated with scholars based in Italy, United States and France. Frequent co-authors include Giuseppe Curigliano, Paolo Tarantino, Carmen Criscitiello, Emanuela Ferraro, Antonio Marra, Giulia Viale, Dario Trapani, Sara M. Tolaney, Paolo D’Amico and Bruno A. Duso. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and JNCI Journal of the National Cancer Institute.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.